<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513992</url>
  </required_header>
  <id_info>
    <org_study_id>S58243</org_study_id>
    <nct_id>NCT02513992</nct_id>
  </id_info>
  <brief_title>Ictal SPECT With Intra-arterial Injection</brief_title>
  <official_title>Early Ictal SPECT With Intra-arterial Injection to Localize the Ictal Onset Zone in Refractory Focal Epilepsy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ictal SPECT with intravenous injection in a cubital vein of a perfusion tracer is an
      established technique to localize the ictal onset zone during presurgical evaluation of
      refractory focal epilepsy. When seizures last less than 10 seconds, localizing information is
      often not obtained. Since it takes around 30 seconds before the tracer reaches the brain
      after intravenous injection, ictal hyperperfusion most likely has already switched to
      postictal hypoperfusion. In this study, we plan to inject the perfusion tracer in the aorta
      proximal to the cerebral arteries, which will allow a true ictal injection in patients with
      seizures of short duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators will select one patient with refractory focal epilepsy with
      frequent seizures of short duration, which can not be localized with early ictal SPECT with
      intravenous injection in a cubital vein. An arterial catheter will be inserted. The right
      groin will be disinfected using an alcoholic disinfectant and locally anaesthetized. The
      artery in the groin, the femoral artery, will be punctured. A catheter is inserted in the
      artery and slided towards the heart. To determine the correct position of the catheter
      proximal to the cerebral arteries, a contrast agent will be injected, and at the same time
      radiographs will be taken. The catheter will be attached and taped in the groin. The patient
      will be monitored with video-EEG recording. During an epileptic seizure, the perfusion tracer
      99m-Technetium Ethyl Cysteinate Dimer (99mTc- ECD) dissolved in 30 cc normal saline will be
      injected with a pressure injector over 2 seconds. After injection, the catheter will be
      removed and the ictal SPECT scan will be performed. Subtracted ictal SPECT images
      co-registered with MRI (SISCOM) will be obtained. The investigators plan to do this study in
      one patient in order to assess whether this procedure is logistically possible and to
      determine whether subtraction images of ictal SPECT with intra-arterial injection minus
      interictal SPECT with intravenous injection allows localization of the ictal onset zone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correct localization of the ictal onset zone</measure>
    <time_frame>1 year after epilepsy surgery</time_frame>
    <description>seizure free outcome will be assessed 1 year after epilepsy surgery and correlated with Subtracted ictal SPECT co-registered with MRI (SISCOM) results</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>intra-arterial injection of tracer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The perfusion tracer 99m-Technetium Ethyl Cysteinate Dimer will be injected via an intra-arterial catheter by a pressure injector to obtain a subtracted ictal SPECT co-registered with MRI (SISCOM)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intra-arterial injection of tracer</intervention_name>
    <description>intra-arterial ictal injection of perfusion tracer</description>
    <arm_group_label>intra-arterial injection of tracer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>99m-Technetium Ethyl Cysteinate Dimer</intervention_name>
    <description>administration of perfusion tracer 99m Tc-ECD during epileptic seizure</description>
    <arm_group_label>intra-arterial injection of tracer</arm_group_label>
    <other_name>99m Tc-ECD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intra-arterial catheter</intervention_name>
    <description>placement of intra-arterial catheter via femoral artery</description>
    <arm_group_label>intra-arterial injection of tracer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pressure injector</intervention_name>
    <description>the injection of the perfusion tracer will be delivered with a pressure injector</description>
    <arm_group_label>intra-arterial injection of tracer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Refractory unifocal epilepsy

          -  Early ictal SPECT with intravenous injection did not localize the ictal onset zone

          -  Several seizure per day, or clusters of several seizures per day

          -  Seizures are of short duration (i.e. less than 10-15 seconds)

          -  Patient asks for epilepsy surgery

        Exclusion Criteria:

          -  Renal failure

          -  Allergy to contrast agents

          -  Fever

          -  Anemia

          -  Usage of anticoagulants

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wim Van Paesschen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven/KU Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wim Van Paesschen, MD, PhD</last_name>
    <phone>+32.16.344332</phone>
    <email>Wim.vanpaesschen@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Leuven, department of Neurology</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wim Van Paesschen, MD, PhD</last_name>
      <phone>+ 32 16 344280</phone>
      <email>wim.vanpaesschen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Van Paesschen Wim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain. 2003 May;126(Pt 5):1103-11.</citation>
    <PMID>12690050</PMID>
  </reference>
  <reference>
    <citation>Van Paesschen W. Ictal SPECT. Epilepsia. 2004;45 Suppl 4:35-40. Review.</citation>
    <PMID>15281956</PMID>
  </reference>
  <reference>
    <citation>Van Paesschen W, Dupont P, Sunaert S, Goffin K, Van Laere K. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol. 2007 Apr;20(2):194-202. Review.</citation>
    <PMID>17351491</PMID>
  </reference>
  <reference>
    <citation>Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Review.</citation>
    <PMID>18514079</PMID>
  </reference>
  <reference>
    <citation>Tousseyn S, Dupont P, Goffin K, Sunaert S, Van Paesschen W. Correspondence between large-scale ictal and interictal epileptic networks revealed by single photon emission computed tomography (SPECT) and electroencephalography (EEG)-functional magnetic resonance imaging (fMRI). Epilepsia. 2015 Mar;56(3):382-92. doi: 10.1111/epi.12910. Epub 2015 Jan 29.</citation>
    <PMID>25631544</PMID>
  </reference>
  <reference>
    <citation>Cleeren E, Casteels C, Goffin K, Janssen P, Van Paesschen W. Ictal perfusion changes associated with seizure progression in the amygdala kindling model in the rhesus monkey. Epilepsia. 2015 Sep;56(9):1366-75. doi: 10.1111/epi.13077. Epub 2015 Jul 15.</citation>
    <PMID>26174547</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2015</study_first_submitted>
  <study_first_submitted_qc>July 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Prof Dr W Van Paesschen</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>ictal SPECT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

